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Telomere Shortening and Tumor Formation
by Mouse Cells Lacking Telomerase RNA
MarõÂa A. Blasco,1,3,7 Han-Woong Lee,2,7 during DNA replication (reviewed in Blackburn, 1991).
The RNA component of telomerase provides the tem-M. Prakash Hande,4 Enrique Samper,3
plate for telomere repeat synthesis (Greider and Black-Peter M. Lansdorp,4,5 Ronald A. DePinho,2,8
burn, 1989; Yu et al., 1990). The human and mouseand Carol W. Greider1,6,8
telomerase RNA components have been cloned (Blasco1Cold Spring Harbor Laboratory
et al., 1995; Feng et al., 1995), and one protein associ-PO Box 100
ated with mammalian telomerase was identified recentlyCold Spring Harbor, New York 11724
(Harrington et al., 1997; Nakayama et al., 1997).2Department of Microbiology and Immunology
In most human primary cells, telomerase activity isAlbert Einstein College of Medicine
not detected, and telomeres shorten with each cell divi-Bronx, New York 10461
sion. If cells are transfected with a viral oncogene, se-3Department of Immunology and Oncology
nescence can be bypassed, and most of the cells willCentro Nacional de BiotecnologõÂa/CSIC
die at a point defined as ªcrisis.º In the establishedUniversad Autonoma Madrid, Campus Cantoblanco
cultures that are recoveredafter crisis, telomerase activ-Madrid E-28049
ity is detected, and telomere length is stabilized orSpain
lengthened. The appearance of telomerase-positive cells4Terry Fox Laboratory
after crisis maybe due to theselective growth advantageBritish Columbia Cancer Research Center
of cells that have stochastically activated telomerase atVancouver, British Columbia, V5Z 1L3
crisis (Counter et al., 1992; reviewed in Autexier andCanada
Greider, 1996).5Department of Medicine
Telomerase activity is detectable in 80% to 90% ofUniversity of British Columbia
human tumor samples, while the normal adjacent tissueVancouver, British Columbia
usually lacks measurable activity (reviewed in Harley etCanada
al., 1994; Kim et al., 1994, Shay and Bacchetti, 1997).
Although the mechanism of activation of telomerase in
tumors is not known, the correlation between telo-Summary
merase activation during cellular immortalization and
activation in tumors led to the view that telomeraseTo examine the role of telomerase in normal and neo-
is required for tumor growth in vivo, and telomeraseplastic growth, the telomerase RNA component (mTR)
inhibition was proposed as a new approach to cancerwas deleted from the mouse germline. mTR2/2 mice
therapy (Harley, 1990; Counter et al., 1992).lacked detectable telomerase activity yet were viable
Mouse tumors, like human tumors, express elevatedfor thesix generations analyzed. Telomerase-deficient
levels of telomerase activity (Bednarek et al., 1995; Cha-cells could be immortalized in culture, transformed by
deneau et al., 1995; Blasco et al., 1996; Broccoli et al.,viral oncogenes, and generated tumors in nude mice
1996). In transgenic mouse models of tumorigenesis,following transformation. Telomeres were shown to
telomerase is activated late in tumor progression, whileshorten at a rate of 4.8 6 2.4 kb per mTR2/2 generation.
the RNA component is upregulated early (Blasco et al.,Cells from the fourth mTR2/2 generation onward pos-
1996; Broccoli et al., 1996). To test whether telomerasesessed chromosome ends lacking detectable telo-
is required for tumor formation and cell viability, wemere repeats, aneuploidy, and chromosomal abnor-
generated mice deleted for the gene encoding the telo-malities, including end-to-end fusions. These results
merase RNA component. We describe here the effectsindicate that telomerase is essential for telomere
of theabsence of telomerase activity on telomere length,length maintenance but is not required for establish-
cellular viability, immortalization, neoplastic transforma-ment of cell lines, oncogenic transformation, or tumor
tion, and tumor formation in nude mice.formation in mice.
ResultsIntroduction
Generation of Viable Mice HomozygousTelomeres protect chromosomes, preventing fusions,
Null for the mTR Locusrecombination, and degradation (reviewed in Greider,
To generate a mouse deficient for telomerase activity,1996). Telomerase is a ribonucleoprotein DNA polymer-
we deleted the germline copy of the mouse telomerasease that plays a key role in telomere synthesis (Greider
RNA gene (mTR) (Thomas and Cappechi, 1987). Geno-and Blackburn, 1985; Yu et al., 1990; Singer and Gottsch-
mic Southern blots probed with the transcribed regionling, 1994). Telomerase adds telomere repeats onto
of the mouse telomerase RNA gene identified a singlechromosome ends to compensate for sequence loss
band, suggesting that mTR is a single copy gene (data
not shown). To delete the mTR gene from the mouse
6 Present address: Department of Molecular Biology and Genetics,
germline, we constructed the plasmid pPNT-mTRD,Johns Hopkins University School of Medicine, Baltimore, Maryland,
which allows replacement of the entire mTR gene with21205.
the neomycin resistance gene (Figure 1A; see Experi-7 These authors contributed equally to this work.
8 To whom correspondence should be addressed. mental Procedures). Using standard protocols, WW6
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Figure 1. Genomic Replacement of the mTR
Locus
(A) The restriction map of the wild-type mTR
locus, the pPNT-mTRD plasmid, and the tar-
geted deletion locus are shown. Recombina-
tion (shown as large Xs) between the tar-
geting vector and the wild-type locus will
eliminate the HSV TK gene and produce the
knockout allele shown below. Two SacI re-
striction sites (shown as SacI) were engi-
neered to allow the wild type and knockout
genomic loci to be distinguished. The 1.2 kb
XhoI-SacI fragment labeled probe will identify
a 6.3 kb wild-type band and a 4.7 kb deletion
allele band in SacI genomic digests.
(B) Southern blot analysis of progeny from
mTR1/2 intercrosses. Genomic DNA isolated
from the tails of the progeny of a mTR1/2
cross was digested with SacI. Southern blots
were probed with the 1.2 kb XhoI-SacI probe.
The bands corresponding to the wild type (6.3
kb) and to the mutant (4.7 kb) are indicated.
mouse embryonic stem (ES) cells (Ioffe et al., 1995) het- MEF cultures from mTR1/1, mTR1/2, and mTR2/2 G1
embryos were assayed for telomerase activity. mTR1/1erozygous for the mTR gene replacement were identi-
and mTR1/2 MEFs had detectable telomerase activity,fied. The mTR1/2 ES cells were used to generate chime-
while MEFs derived from mTR2/2 embryos showed noric progeny that transmitted the neomycin resistance
detectable activity as assayed by the sensitive telomericgene through the germline (Ramirez-Solis et al., 1993).
repeat amplification protocol (TRAP) assay (Kim et al.,The chimeric mice were backcrossed to C57BL/6J mice
1994) (Figure 2A).before intercrossing them to generate the first genera-
To test whether telomerase activity was present intion (G1) mTR-deficient mice. Intercrosses between
adult mouse tissues, S100 extracts from brain, liver,mTR1/2 heterozygous mice generated viable mTR2/2
thymus, and spleen from mTR1/1, mTR1/2, and mTR2/2offspring.
littermates were assayed using the TRAP assay. Telo-A probe flanking the mTR locus detected a 6.3 kb
merase activity was detected in liver and thymus fromSacI restriction fragment in wild-type mice and a 4.7 kb
both mTR1/1 and mTR1/2 mice but not detected in theseSacI restriction fragment at the targeted locus (Figure
tissues from mTR2/2 mice (Figure 2B and data not1B). Disruption of the mTR locus was verified on three
shown). For all the genotypes, no activity was detectedadditional levels. First, Southern blotsof tail DNA probed
in adult brain or spleen, which were shown previously towith the mTR transcribed region showed a band in wild-
be telomerase negative (Chadeneau et al., 1995; Prowsetype but not in mTR2/2 animals (data not shown). Sec-
and Greider, 1995).ond, Northern blots of total RNA isolated from mouse
The TRAP assay for telomerase activity is based onembryonic fibroblasts (MEFs) showed that the mTR tran-
the PCR amplification of telomerase products con-script was not detectable in total RNA derived from
taining the sequence (TTAGGG)n (Kim et al., 1994). OnlymTR2/2 mouse embryos (data not shown). Finally,analy-
repeats of this sequence will be amplified in the PCRsis of mTR2/2 animals showed no detectable telomerase
reaction. To determine whether some other sequence
activity (see below).
might be synthesized by telomerase in the absence of
The generation of mTR2/2 mice indicated that mTR is
the mTR gene, we used a direct assay to visualize se-
not essential for embryonic development. To determine quences added onto telomeric primers (Prowse et al.,
whether the mTR2/2 mice are fertile, first generation 1993). Using two different telomerase substrates,
(G1) mTR2/2 mice were crossed to each other. Second (TTAGGG)3 and MP 1 (Blasco et al., 1995), the expected
generation (G2) mTR2/2 mice were obtained, indicating ladder of primer elongation products was generated
that mTR is not essential for fertility. Additional genera- with extracts prepared from mTR1/1 MEFs but not from
tions of mTR2/2 mice were obtained by crossing two extracts prepared from mTR2/2 MEFs (data not shown).
animals that were deleted for the mTR locus and desig- The absence of telomerase activity in mTR2/2 MEFs
nated G3, G4, G5, and G6. In all cases, in our nomencla- and tissues indicates that the mTR gene is essential for
ture, the parents of a given mTR2/2 generation were mouse telomerase activity in vivo.
both from the previous generation. Thus, a G3 mTR2/2 To determine if mTR2/2 cells retain the ability to ex-
animal is derived from crossing two G2 mTR2/2 mice. press telomerase activity, we reintroduced the wild-type
gene into mTR2/2 MEF cultures by transient transfection
mTR2/2 Mice and Embryonic Fibroblasts Lack (see Experimental Procedures). Cell cultures transfected
Telomerase Activity with a plasmid containing 5 kb surrounding the genomic
To determine whether deletion of mTR abolished telo- mTR locus (Blasco et al., 1995) had detectable te-
lomerase activity 48 hr after the transfection. In contrast,merase activity as expected, five independently derived
Telomerase Null Mice
27
Figure 2. Telomerase Activity in mTR1/1, mTR1/2, and mTR2/2 Fibroblasts
(A) S100 extracts were prepared from early passage mouse embryonic fibroblasts, mTR1/1, mTR1/2, and mTR2/2 and assayed for telomerase
activity. All the extracts were pretreated (1) or not (2) with RNase A before the telomerase assay. The protein concentration in mg/ml in the
PCR step of the enhanced TRAP assay is indicated in the figure.
(B) TRAP assay of telomerase activity in mTR1/1, mTR1/2, and mTR2/2 thymus extracts. S100 extracts were pretreated (1) or not (2) with
RNase A as indicated in the figure. The final protein concentrations in the TRAP assay are indicated. The arrow indicates the position of the
internal control (IC) for PCR efficiency.
(C) Rescue of telomerase activity in an mTR2/2 cell line. A plasmid containing 5 kb of mouse genomic DNA that contained the mTR gene and
upstream sequences (Blasco et al., 1996) or an empty vector (Bluescript) was transfected into a mTR2/2 cell line (KO-3 at passage 23). Forty-
eight hours after transfection, S100 extracts were prepared and assayed for telomerase activity. All the extracts were pretreated (1) or not
(2) with RNase before the telomerase assay. The protein concentration is given in mg/ml in the PCR step of the enhanced TRAP assay.
mTR2/2 cultures transfected with an empty vector had as G2, G3, G4, and G6 mTR2/2 MEF cultures showed
the typical slow growth phase around 10 PDL charac-no detectable telomerase activity (Figure 2C). Restora-
tion of telomerase activity in vivo with ectopically ex- teristic of senescence/crisis (Figure 3A and data not
shown). The cells adopted a flat and extended morphol-pressed mTR indicates that it is the absence of the
telomerase RNA that is responsible for the loss of telo- ogy with prominent cytoplasmic enlargement during the
senescence/crisis period (data not shown). After severalmerase activity in mTR2/2 cells. Further, it suggests that
either the telomerase protein components are present passages of slow growth, all the cultures regained a
rapid growth rate, characteristic of established cells. Toin the cell even in the absence of mTR or the expression
of mTR rapidly induces the protein components to form date, the MEF cultures derived from G1 embryos have
an active mouse telomerase complex.
Establishment of Telomerase Null Embryonic
Fibroblast Cultures
The presence of telomerase activity in immortalized hu-
man and mouse cell cultures and the frequent activation
of telomerase in human and mouse tumors suggested
that telomerase activity might be required for the growth
of immortalized cells (reviewed in Autexier and Greider,
1996). To test this hypothesis, we compared the ability of
telomerase-negative (mTR2/2) and telomerase-positive
(mTR1/1) MEFs to generate established cell lines using
the 3T3 protocol (Todaro and Green, 1963) (see Experi-
mental Procedures). Primary MEF cultures were gener-
ated from mTR1/1, mTR1/2, and mTR2/2 G1 embryos Figure 3. Establishment and Growth of mTR and mTR2/2 MEFs in
and from mTR2/2 G2, G3, G4, and G6 embryos (see Culture
Experimental Procedures). Primary cultures of mTR2/2 (A) The growth characteristics of MEF cultures from wild type, G1,
G2, G3, G4, and G6 mTR2/2 embryos are shown. The cultures wereMEFs were morphologically indistinguishable from
derived from individual embryos and passaged according to themTR1/1 and mTR1/2 MEFs (data not shown). The initial
3T3 protocol (see Experimental Procedures). The following mousegrowth rates of mTR1/1, mTR1/2, and mTR2/2 MEFs
embryonic fibroblasts were studied: Wt-6 (closed squares); mTR2/2from the first generation and mTR2/2 MEFs from genera-
KO-G1 (open diamonds); KO-G2 (open circles); KO-G3 (open
tions G2, G3, G4, and G6 were similar (Figure 3A). At a squares); KO-G4 (closed circles); and KO-G6 (closed triangles). The
population doubling level (PDL) of approximately 10, number of population doublings was calculated as follows: DPDL
5 log(nf/n0)/log2, where n0 is the initial number of cells and nf is thenormal primary MEFs enter a slow growth phase that
final number of cells at each passage.has been described in mouse cells as senescence or
(B) Long-term growth of mTR1/1, mTR1/2, and mTR2/2 establishedcrisis (Todaro and Green, 1963; Conzen and Cole, 1995;
cell lines. MEF cultures were derived from mTR1/1, mTR1/2, andRittling, 1996). Spontaneous escape from this senes-
mTR2/2 G1 embryos and established in culture following the 3T3
cence/crisis phase occurs in normal rodent cells at a protocol. mTR1/1 Wt-4 (closed squares); mTR1/2 H-1 (open trian-
frequency of 2 3 1026 (Kraemer et al., 1986). Serial pas- gles); mTR1/2 H-5 (hatched squares); mTR1/2 H-9 (open diamonds);
mTR2/2 KO-3 (open circles).sage of G1 mTR1/1, mTR1/2, and mTR2/2 MEFs as well
Cell
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Table 1. Colony Formation Assay and only a relatively short terminal portion of telomeric
repeats (Kipling et al., 1991; Zijlmans et al., 1997).Cell Typea Total Colonies 1b Total Colonies 2c
To determine if telomere shortening occurs when telo-
Wt-1 22 13
merase activity is absent, we used both the SouthernKO G2-2 26 14
blot and the FISH techniques. For the former, primaryKO G3-4 31 4
MEF cultures were derived from G1 mTR1/1 animals andKO G4-10 22 14
KO G4-4 13 16 from the mTR2/2 G1, G2, G3, G4, and G6 generation
KO G4-8 13 8 embryos. Genomic DNA was digested with MboI, re-
KO G6-9 22 19 solved on a pulsed-field gel, blotted, and probed with
KO G6-11 9 42
a (TTAGGG)n probe to detect the terminal fragments (see
a The genotype (Wt for mTR1/1 and KO for mTR2/2), generation Experimental Procedures). Primary cell cultures derived
(G2±G6), and culture number of the MEF cells plated in the assay from individual mice from the different generations had
are given. Three independently derived cultures were used from very different TRF sizes, as expected from the hypervari-
mTR2/2 G4 embryos and two independent cultures from G6 em-
able nature of mouse TRFs (Kipling and Cooke, 1990).bryos.
Thus, from this analysis it was not possible to distinguishb In the first experiment,colonies were identified by visual inspection
of plates after 2 weeks of growth. whether telomeres were shorter in the G6 compared to
c In the second experiment, colonies were identified in the micro- the wild-type animals (Figure 4A).
scope to avoid counting large senescent cells as colonies. To look further for telomere shortening, we analyzed
MEF cultures from wild-type and mTR2/2 G1, G3, and
G4 animals. DNA was isolated from cells during early,
mid, and late passage of these cultures. Although there
undergone more than 200 PDL, and those derived from
again was significant variability in the fragment size in
the later generations (G2±G6) have divided for at least
cultures derived from individual embryos, it was appar-
40 PDL (Figure 3B and data not shown).
ent that the telomere bands shortened during growth in
To quantitate the ability of mTR1/1 and mTR2/2 cell
culture (Figure 4B). As a control, we probed the same
cultures to generate established lines, we used a colony
blot with the major satellite repetitive DNA element (Kip-
formation assay. The ability of primary cell cultures to
ling and Cooke, 1990) and found no decrease in the size
produce colonies when plated at low density is related
of the repetitive sequence bands with increased cell
to the proliferative potential of cells and the ability to
generation in culture. Thus, the decrease of fragment
escape senescence/crisis (Kraemer et al., 1986; Conzen
size seen in Figure 4B is not due to a general change
and Cole, 1995; Serrano et al., 1996). In contrast to
in repetitive DNA or to an artifact of gel running. We
serial passage, a colony formation assay provides a
conclude that the telomere fragments shorten during
quantitative estimate of the immortalization efficiency.
cell doublings in culture in the absence of telomerase.
MEFs derived from mTR2/2 G1±G4 and G6 mice formed
To obtain more quantitative information on telomere
colonies with a similar efficiency to MEFs derived from
shortening, we used FISH analysis (Lansdorp et al.,
mTR1/1 mice (Table 1). Thus, telomerase-negative cells
1996; Zijlmans et al., 1997). The signal intensity of telo-
can overcome senescence/crisis at a rate similar to telo-
meric DNA visualized by FISH can be related to the
merase-positive cells.
approximate number of kilobase pairs of (TTAGGG)n
repeat sequence present on a given chromosome end.
Telomere Length in Telomerase Null Cells One telomere fluorescence unit (TFU) is defined as the
Telomerase activity is thought to be required for telo- signal that represents 1 kb of (TTAGGG)n repeat (Zijl-
mere length maintenance in mammals, as it is in yeast. mans et al., 1997; see Experimental Procedures). Pri-
In human primary fibroblasts that lack detectable telo- mary MEF cultures were derived from wild-type and
merase activity, telomeres shorten by about 100 bp per mTR2/2 G2, G4, and G6 animals, and the fluorescence
cell division (Harley et al., 1990; Counter et al., 1992). intensity on all chromosome ends from 25 or more meta-
The terminal restriction fragment (TRF) containing the phase samples at each generation was determined (Fig-
telomeric repeats in human cells is typically between 10 ure 5 and Table 2). These cultures revealed a significant
and 15 kb in length. Some mouse species such as Mus decrease in TTAGGG hybridization signal with increas-
spretus have a similar TRF length and rate of telomere ing mTR2/2 generation. The rate of telomere shortening
shortening in primary fibroblasts (Prowse and Greider, was 4.8 6 2.4 kb per mouse generation. This value was
1995). The laboratory mouse species Mus musculus calculated by comparing the mean of the TFU distribu-
used to generate the mTR2/2 strain has TRFs that have tions for the p arm, the q arm, and for all ends between
been estimated on pulsed-field gels to range from 40 wild type and mTR2/2 G2, G4, and G6. Representative
to 150 kb (Kipling and Cooke, 1990; Starling et al., 1990). FISH images from wild-type mTR2/2 G2, G4, and G6
However, recent experiments using fluorescence in situ MEF cultures are shown in Figure 6. Strikingly, no
hybridization (FISH) suggest that the TTAGGG repeats TTAGGG signal was detected on chromosome ends in
on mouse chromosomes range from only 10 to 60 kb 5% of the chromosomes in G6 cultures (Figure 6D and
(Zijlmans et al., 1997). The difference between the esti- Table 2).
mates of telomere length determined using FISH and The lack of detectable TTAGGG signal on some chro-
that determined by Southern blot is likely due to the mosomes suggests that telomere function, which nor-
scarcity of restriction sites in the subtelomeric repetitive mally caps or stabilizes chromosome ends, might be
DNA on the mouse chromosomes. Thus, the very long lost on those ends. Consistent with this, increased fre-
quencies of aneuploid cells and apparent end-to-endTRFs may consist mostly of subtelomeric repetitiveDNA
Telomerase Null Mice
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Figure 4. TRF Length in mTR2/2 Mouse Embryonic Fibroblasts
(A) Early passage MEFs derived from different generations of the mTR2/2 embryos were grown, and the samples were embedded in agarose
plugs and pulsed-field gels were run as described (see Experimental Procedures). The wild-type (Wt) mice had been backcrossed to C57BL/
6J for five generations, while the G2, G4, and G6 mTR2/2 cells had not been backcrossed.
(B) MEF cell cultures were established from wild type or different generations of mice bred in the absence of telomerase (mTR2/2 G1, G3, or
G4). The cells were passaged in culture for the number of PDL indicated, and genomic DNA was prepared and resolved on a pulsed-field
gel. After probing with (TTAGGG)n, the blot was stripped and reprobed with the mouse major satellite probe to control for gel artifacts loading
and integrity of the DNA sample.
associations of chromosomes including Robertsonian nude mice. Late passage, established G1 mTR2/2 and
mTR1/1 MEF cell lines were transfected with a plasmidfusions (see, for example, Garagna et al., 1995; Nanda
et al., 1995) were observed in metaphase spreads from expressing rasv12 alone, T antigen (TAg) alone, or rasv12
plus TAg. The mTR2/2 and mTR1/1 cells formed similardifferent generations of mTR2/2 cultures (Figures 6B±
6D; Table 2). The loss of telomere signal and the con- numbers of foci after transfection, indicating that the
absence of mTR does not inhibit oncogenic transforma-comitant appearance of chromosomal rearrangements
indicates that the absence of telomerase activity leads tion. In addition, rasv12 was sufficient for foci formation
(data not shown), further substantiating that the lateto telomere shortening and chromosome instability.
passage cells derived in the 3T3 experiment were estab-
lished cell lines. Two independent foci for each cell typeMalignant Transformation and Tumor Formation
in the Absence of Telomerase Activity were subcloned, and 105 cells from each clone were
injected into two different sites on a nude mouse. BeforeTo test the requirement for telomerase during mouse
tumorigenesis, we compared cells derived from mTR1/1, injection, each transformed cell line was assayed for
telomerase activity using the TRAP assay. As expected,mTR1/2, and mTR2/2 embryos for their ability to become
neoplastically transformed and then to form tumors in foci derived from mTR1/1 MEFs had telomerase activity,
Figure 5. Frequency Distribution of Telomere
Fluorescence in Metaphase Spreads Pre-
pared from Embryonic Fibroblasts
Early passage MEF cultures were prepared
from mTR1/1 (Wt) and mTR2/2 second gener-
ation (KO-G2), fourth generation (KO-G4), and
sixth generation (KO-G6). The fluorescence
intensity of individual telomeres and, sepa-
rately, the p-arm telomeres and q-arm telo-
meres are shown for all 25±31 metaphases
analyzed at each generation. Telomere fluo-
rescence intensity is expressed so that 1 telo-
mere fluorescence unit (TFU) corresponds to
1 kb of (TTAGGG)n sequence, according to
resultsobtained from similarly hybridized and
analyzed plasmids with a defined (TTAGGG)n
length (Zijlmans et al., 1997). The differences
in mean fluorescence intensity were signifi-




Table 2. Summary of Cytogenetic Observations and Quantitative FISH Data in Primary Embryonic Fibroblasts from mTR1/1 and
mTR2/2 Mice
Telomeres without End-to-End TFUs of Individual Telomeres (Mean 6 SD)
Metaphases Aneuploidy Detectable Associations/Fusions
Analyzed (% Cells)a TTAGGG Repeats (%)b (Frequency per Metaphase)c All p-arm q-arm
Wt 26 0 0 0 43.8 6 16.8 37.2 6 12.7 50.5 6 17.8
KO-G2 31 23 58 (1.1) 0.26 29.0 6 18.0 22.8 6 14.7 35.1 6 18.8
KO-G4 25 28 96 (2.4) 0.56 25.0 6 16.6 18.1 6 11.4 31.9 6 18.0
KO-G6 27 56 282 (5.3) 1.93 13.9 6 10.6 9.7 6 7.7 18.0 6 11.5
Wt 5 Wild type; KO-G2, KO-G4, and KO-G6 represent mTR2/2 mice of second, fourth, and sixth generations, respectively.
a Expressed as percentage of metaphases with other than 40 chromosomes (each Robertsonian fusion was counted as two chromosomes).
b The total number of telomeres lacking TTAGGG signal is shown. The number in parentheses is the percent of all ends. For this calculation,
each metaphase chromosome was expected to show four fluorescent spots. If only two spots were observed, the corresponding telomere
was assumed to lack detectable TTAGGG at one end. We estimate that those ends lacking telomere signals have ,0.2 kb TTAGGG repeats.
c Expressed as total number of end-of-end associated chromosomes per metaphase, including dicentric chromosomes, telomere associations,
and Robertsonian fusions.
whereas those derived from mTR2/2 MEFs had no de- mTR2/2 mice, telomeres shortened at a rate of 4.8 6 2.4
kb per mouse generation. From one mouse generationtectable telomerase activity (data not shown). All trans-
formed cell lines had a similar morphology and growth to the next, there are about 62 cell divisions in the male
and 25 in the female germline (Drost and Lee, 1995). Onrates in culture. When injected, both G1 mTR2/2 and
mTR1/1 transformed cell lines generated tumors in nude a per cell division basis, a loss rate of 50 to 100 base
pairs, as seen in human and M. spretus primary cellsmice, while untransformed control cells did not (Figure
7A). These results indicate that telomerase activity per (Harley et al., 1990; Allsopp et al., 1992; Prowse and
Greider, 1995), would generate a 3-to-6-kb loss in these is not essential for transformed cells to form tumors
in nude mice. male germline and a 1-to-3-kb loss in the female germ-
line. Our experimental data fit this prediction remarkablyBecause established cell lines may have multiple ge-
netic changes and may have activated an alternative well. This agreement between the rate of telomere short-
ening in mTR2/2 mice and primary fibroblasts supportstelomere maintenance pathway, we also used primary
MEFs todetermine the role of telomerase in cell transfor- the hypothesis that telomere shortening in primary cells
is due to the lack of telomerase activity as proposedmation and tumor growth. Early passage MEF cultures
from G1 mTR1/1 and mTR1/2 and G1, G2, G3, G4, and (Cooke and Smith, 1986; Harley et al., 1990; Hastie et
al., 1990).G6 mTR2/2 mice were infected with a retrovirus carrying
a construct that directs the expression of the adenovirus Aneuploidy and chromosomal end fusions were fre-
quent in cultures from mTR2/2 mice in G2 to G6 cultures,E1A, rasv12, and the puromycin drug resistance gene
(see Experimental Procedures). After infection, foci were providing striking evidence that the ability of telomeres
to protect chromosome ends is lost when telomeraseselected, and 105 cells were injected at a total of four
sites in nude mice to assay tumor formation. Tumors is absent and telomere shortening occurs. The appear-
ance of Robertsonian fusions is of particular interest,were generated from the mTR1/1 and all of the mTR2/2
G1, G2, G3, G4, and G6 derived cells after a similar since this type of rearrangement has been predicted
to result from loss of telomere function. Robertsonianlatency. Although there was significant variation in tumor
size, cells derived up to the sixth generations of mTR2/2 chromosomal rearrangements in mice typically lack
pericentromeric telomeric DNA and contain variableanimals were capable of tumor formation (Figures 7B
and 7C). These data indicate that telomerase null cells amounts of minor satellite sequences, indicating the
elimination of substantial amounts of chromosomal DNAcan form tumors in nude mice.
during their formation (Garagna et al., 1995; Nanda et
al., 1995). The Robertsonian fusions observed in mTR2/2Discussion
mice also lack pericentromeric telomeric DNA but are
not expected toshow lossof minor satellite DNA. FurtherTelomerase activity has been proposed to be required
for cell immortalization and tumor progression in hu- analysis of the molecularcomposition of the metacentric
fusion area and the stability of mTR2/2 Robertsonianmans and mice (reviewed in Autexier and Greider, 1996).
To evaluate the role of telomerase in mammalian devel- fusion chromosomes will provide important insights into
the generation of these chromosome fusions.opment, cell growth, and tumor formation, we deleted
the gene encoding the telomerase RNA component from Human cells will stop dividing or senesce after 40 to
80 cell divisions, and permanent lines are only generatedthe mouse germline. Cells and tissues from mTR2/2 mice
lacked detectable telomerase activity. The mTR2/2 mice if senescence is bypassed by oncogenic virus or muta-
tion. Immortal cells can be selected after a growth crisisare viable through at least six generations. Quantita-
tive FISH analysis showed that progressive loss of in the oncogene-expressing culture. In contrast, mouse
and other rodent cell cultures undergo a period of slow(TTAGGG)n telomere sequence repeats occurred with
each generation and that chromosomal rearrangements growth and then spontaneously generate established
cell lines (Todaro and Green, 1963). The period of slowwere frequent in the later generations of mice.
The rate of telomere shortening in mouse cells ap- growth in MEFs has been referred to in the literature as
either senescence (Meek et al., 1977; Harvey and Levine,pears to be similar to that reported for humans cells. In
Telomerase Null Mice
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Figure 6. Telomere Fluorescence of Meta-
phase Chromosomes from Embryonic Fibro-
blasts
Fibroblasts from mTR1/1 (Wt) and indicated
generations of mTR2/2 null mice (KO, G2±
G6) were hybridized with a Cy3 labeled
(CCCTAA)3 PNA probe. Arrows indicate telo-
meres without detectable TTAGGG. Images
were obtained using a Zeiss Axioplan fluores-
cence microscope coupled to a charge-cou-
pled device (CCD) camera. Separate images
of DAPI-stained chromosomes and telo-
meres hybridized with (CCCTAA)3 PNA probe
were merged and assigned pseudocolors us-
ing Adobe Photoshop (Adobe Systems,
Mountain View, California).
(A) Metaphase from Wt cells showing distinct
bright signal intensities for all telomeres.
(B) A KO-G2 cell showing decreased overall
fluorescence and occasional absence of telo-
mere fluorescence signal.
(C) A KO-G4 metaphase showing strong het-
erogeneity in the telomere signal intensities.
Many telomeres show little if any fluores-
cence (arrows), yet bright telomere staining
can be seen on some chromosome ends.
(D) Metaphase from a KO-G6 cell. Note the
overall weaker telomere fluorescence and the
increased frequency of telomeres without detectable TTAGGG. Two Robertsonian fusions in this metaphase were observed with no detectable
TTAGGG at the fusion point (arrow).
1991; Ikram et al., 1994) or crisis (Kraemer et al., 1986; divisions in vivo still formed tumors. Thus, while telo-
merase is activated in mouse tumors in vivo (BednarekRittling, 1996). We found no difference in the ability to
overcome senescence/crisis between the G1 mTR1/1, et al., 1995; Chadeneau et al., 1995; Blasco et al., 1996;
Broccoli et al., 1996), it appears not to be required formTR1/2, and G1 through G6 mTR2/2 primary cultures
using both the 3T3 growth protocol and the colony for- growth during the 40 or more divisions necessary for
tumor formation. This raises the question of why telo-mation assay. Strikingly, some chromosomes in mTR2/2
G2 and later primary MEF cultures lacked detectable merase is activated in mouse tumors if it is not essential
for tumor growth. Although initial work with human cellstelomeric repeats. While the induction of senescence
may differ in human and mouse cells, our data in mouse suggested that telomerase was required for tumor cell
viability after critical telomere shortening, recent studiescells suggest that telomere length is not a primary deter-
minant of senescence/crisis in mouse cells and that of mouse tumors concluded that telomerase was acti-
vated even in the absence of critical telomere shorteningtelomerase activity is not required in mouse cells to
allow escape from the senescence/crisis point. (Broccoli et al., 1996). At the time of their report, it was
not clear how many divisions a mouse cell could un-A striking finding from this work is that oncogenically
transformed telomerase null mouse cells with severely dergo without telomerase before viability would be com-
promised. Our data indicate that telomerase null mouseshortened telomeres can form tumors in nude mice. To
generate a sizable tumor from a single cell in a mouse cells can be established in culture and grow for more
than 200 cell divisions without loss of viability and thatrequires only about 40 to 50 cell divisions. Yet, mTR2/2
G6 MEFs that have already undergone over 300 cell mTR2/2 G6 cells that have gone though an estimated 300
Figure 7. Tumor Formation in Nude Mice by
mTR2/2 Transformed Cells
(A) Tumor formation in nude mice from TAg
and rasv12 transformed mTR1/1 and G1
mTR2/2 cells. Each transformed cell line (5 3
105 cells) was injected at a total of four differ-
ent sites (two sites in each of two mice), col-
lected, and weighed 20 days after injection.
Tumor size for each cell line is plotted as
the average of four tumors arising from four
different injection sites (two each on two dif-
ferent mice).
(B) Tumor formation in nude mice injected with E1A and rasv12 transformed cells from wild type and mTR2/2 G1, G2, G3, and G4 embryos.
Transformed cells were selected after infection with the retroviral vector, and 1.5 3 106 cells were injected into nude mice at four independent
sites. The average size of the tumor 47 days after injection is plotted.
(C) A second experiment was done similar to that described in (B) using wild type, mTR2/2 G4 cells, and two different isolates of mTR2/2 G6
cells. A total of 1.5 3 106 cells was injected at four independent sites, and the size of the tumor is shown 55 days after injection.
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DNA generated a 6.3 kb wild-type band or a 4.7 kb band from thecell divisions or more are viable.This furthersupports the
correctly targeteddeletion allele. The site-directed mutagenesis wasnotion that telomerase activation during mouse tumori-
carried out using the Amersham Sculptor In Vitro Mutagenesis sys-genesis may not bea response to critical telomere short-
tem and the sites were confirmed by sequencing. The mutagenized
ening. Perhaps telomerase activation is linked to some fragments were cloned into the targeting vector pPNT (Tybulewicz
other pathway that is essential for tumor growth and et al., 1991) to generate the plasmid pPNT-mTRD. The plasmid con-
tained a neomycin resistance gene for replacement of the mTR geneis passively coselected during tumorigenesis. In fact,
and the HSV TK gene for counterselection in ganciclovir of randomlyevidence is accumulating that telomerase activity may
integrated constructs (Thomas and Cappechi, 1987).be best correlated with a high rate of proliferation in
those cells that express it (Blasco et al., 1996; Broccoli
ES Cell Culture and Blastocyst Injection
et al., 1996; Kyo et al., 1997; Shay and Bacchetti, 1997). To generate ES cells with targeted integration, the pPNT-mTRD
Telomerase-negative cells that escape senescence/ plasmid was linearized with NotI, and the DNA was electroporated
crisis might maintain telomere length by a recombina- into WW6 ES cells (Ioffe et al., 1995) by standard protocols (Ramirez-
Solis et al., 1993). Cells were selected in G418 (100 to 150 mg/ml)tional mechanism. Yeast cells defective for telomere
and ganciclovir (2 mM), and positive clones were picked after 9 tomaintenance but possessing a wild-type recombination
10 days of selection into duplicate 48-well microtiter plates. Of thesystem generate rare ªsurvivorsº after extended growth
449 neomycin/ganciclovir resistant clones initially screened, four
in culture. In these cells, gene conversion allows length- contained a correctly targeted mTR locus (Tel-1, Tel-2, Tel-3, and
ening of telomere repeat tracts. When the yeast RAD52 Tel-4). The four clones were independently injected into C57BL/6J
gene is deleted, gene conversion is severely reduced, blastocysts, and the blastocysts were implanted into pseudopreg-
nant mice. The chimeric progeny were identified by their mosaicand survivors are not generated (Lundblad and Black-
coat color. The mice derived from the Tel-1 microinjections wereburn, 1993; McEachern and Blackburn, 1996). Some hu-
mated to C57BL/6J to test for germline transmission of the mTRman cell lines that lack detectable telomerase activity
gene replacement, and heterozygous mTR1/2 progeny were identi-
are thought to maintain telomeres via such a recombina- fied. To obtain further generations of telomerase null mice, the
tion-mediated pathway (Bryan et al., 1995). Although no mTR2/2 mice were mated to each other. All of the mice described
evidence of greatly elongated telomeres was seen in in this report were derived from Tel-1 ES cells.
early passage mTR2/2 G2 through G6 MEFs using FISH,
Isolation and Growth of Mouse Embryonic Fibroblastsit will be interesting to follow telomeres during establish-
MEFs were prepared from day 13.5 embryos derived from crossesment and long-term growth in culture using this tech-
between either mTR1/2 mice or mTR2/2 mice from different genera-
nique to determine if recombination plays a role in the tions. The whole embryo was minced and dispersed in 0.25% trypsin
selection of cells at senescence/crisis. and incubated for 2 hr at 48C. Cells were plated in 10 cm plates
Although mice provide a powerful tool for understand- containing DMEM plus 10% FBS and incubated at 378C until conflu-
ent. The first passage was designated PDL 2. MEFs were grown ining cancer progression, there aresome significant differ-
DMEM supplemented with 10% fetal bovine serum (FBS). Serialences between human and mouse biology that may have
cultures were done according to the 3T3 protocol (Todaro andimplications for tumor growth. First, human telomeres
Green, 1963). In brief, 106 cells were plated on a 10 cm dish; afterare on average shorter than mouse telomeres. Telomere
3 days, the cells were counted and 106 cells were replated. The
shortening and telomerase activation might play a role population doubling number was calculated using the formula
in human tumor growth and viability while having little DPDL 5 log(nf/n0)/log2, where n0 is the initial number of cells and nf
is the final number of cells. For colony formation assay, 3.5 3 103effect on mouse tumorigenesis. A second major differ-
cells were distributed on a total of ten 6 cm diameter dishes andence between human and mouse tumorigenesis is that
incubated in DMEM plus 10% FBS. After 8 days, the dishes weremouse cells spontaneously immortalize, while human
stained with Giemsa, and the number of visible colonies with .1.5cells do not. Whether this difference represents an addi-
mm diameter was scored.For the reintroduction of mTR into mTR2/2
tional level of growth control in human cells remains cells, a mTR2/2 established cell line, KO-3 at passage 45, was
to be established. Despite these differences between transfected using calcium phosphate procedures (Ausubel et al.,
1993) with 20 mg of a 5 kb genomic fragment containing the mTRhuman and mouse cells, the observation that in mice
gene (Blasco et al., 1995) or an empty Bluescript vector. Forty-eighttelomerase activation occurs after less than 40 divisions,
hours after transfection, cells were collected from the plate, andwhile the enzyme is not required for tumor growth after
S100 extracts were prepared and assayed for telomerase activity.more than 300 divisions, raises the possibility that not
all telomerase-positive human tumors may require telo- Telomerase Assays
merase. It is possible that for some human tumors, te- S100 extracts were prepared from tissues and from cell cultures as
lomerase may be required for growth; however, addi- described previously (Blasco et al., 1995). Telomerase activity was
measured using a modified version (Blasco et al., 1995) of the TRAPtional evidence besides the presence of high levels of
assay (Kim et al., 1994) as well as the conventional telomerase assaytelomerase will be needed to verify this in the light of
(Prowse et al., 1993). For the modified TRAP assay, a telomerasethe data presented here. Further analysis of the mTR-
reaction was first carried out under optimal conditions of the en-
deficient mice may lead to new insights into the role of zyme, and a portion of the products were then amplified by PCR
telomeres in cell biology and in tumorigenesis. (Blasco et al., 1996). When indicated, an internal control for PCR
efficiency was included in the TRAP assay (TRAPeze kit, Oncor).
Experimental Procedures
Pulsed-Field Gel Electrophoresis and TRF Analysis
Cells were isolated and embedded in agarose plugs following in-mTR Knockout Construct
For the mTR genomic deletion, site-directed mutagenesis was used structions from the vendor (CHEF agarose plug kit from Bio-Rad).
DNA embedded in agarose plugs was digested with MboI and elec-to introduce two new unique SacI restriction sites (SacI, Figure 1A)
into a 3.3 kb XbaI genomic fragment and a 4.0 kb XhoI genomic trophoresed through 1% agarose gels in 0.53 TBE maintained at
128C, using a CHEF DR-II pulsed-field apparatus (Bio-Rad). Separa-fragment (Figure 1A). These sites allow the correct homologous
recombination events to be identified by digestion of genomic DNA tion was for 23 hr at 6 V/cm at a constant pulse time of 5 s. The
gel was blotted and probed with a 1.6 kb fragment containing thewith SacI. Using a 1.2 kb probe (indicated in Figure 1), SacI-digested
Telomerase Null Mice
33
sequence (TTAGGG)n (a gift from T. de Lange; see Hanish et al., mammalian cells. In Current Protocols in Molecular Biology. (New
York: Wiley and Sons, Inc.), pp. 9.1.1.1995) and later with the mouse major satellite repeat (a gift from D.
Kipling). Autexier, C., and Greider, C.W. (1996). Telomeraseand cancer: revis-
iting the telomere hypothesis. Trends Biochem. 21, 387±391.
Fluorescence In Situ Hybridization Bednarek, A., Budunova, I., Slaga, T.J., and Aldaz, C.M. (1995).
Primary embryonic fibroblasts from mTR1/1 (wild type) and mTR2/2 Increased telomerase activity in mouse skin pre-malignant progres-
second generation (KO-G2), fourth generation (KO-G4), and sixth sion. Cancer Res. 55, 4566±4569.
generation (KO-G6) were harvested from early passage cultures
Blackburn, E.H. (1991). Structure and function of telomeres. Naturefollowing treatment with colcemid (0.1 mg/ml) for 4 to 5 hr. Cells
350, 569±573.were trypsinized and spun for 8 min at 120 3 g. After hypotonic
Blasco, M.A., Funk, W.D., Villeponteau, B., and Greider, C.W. (1995).swelling in sodium citrate (0.03 M) for 25 min at 378C, the cells were
Functional characterization and developmental regulation of mousefixed in methanol:acetic acid (3:1). After two to three additional
telomerase RNA. Science 269, 1267±1270.changes of fixative, the cell suspension was dropped on wet, clean
slides and dried overnight. FISH with Cy-3 labeled (CCCTAA)3 pep- Blasco, M.A., Rizen, M., Greider, C.W., and Hanahan, D. (1996).
tide nucleic acid (PNA) and quantitative analysis of digital images Differential regulation of telomerase activity and telomerase RNA
was performed as described (Zijlmans et al., 1997). during multi-stage tumorigenesis. Nat. Genet. 12, 200±204.
Broccoli, D., Godley, L.A., Donehower, L.A., Varmus, H.E., and de
Retroviral Infections Lange, T. (1996). Telomerase activation in mouse mammary tumors:
Phoenix cells (5 3 106) were plated in a 10 cm dish, incubated for lack of detectable telomere shortening and evidence for regulation
24 hr, and then transfected by calcium phosphate precipitation with of telomerase RNA with cell proliferation. Mol. Cell. Biol. 16, 3765±
25 mg of a retroviral plasmid pLPC-EIR (a gift from S. Lowe). This 3772.
construct is based on a Maloney retrovirus expressing puromycin
Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S., and Reddel,
phosphotransferase from the LTR and coexpressing E1A 12S cDNA
R.R. (1995). Telomere elongation in immortal human cells without
and oncogenic rasv12 cDNA from the CMV promoter via an internal detectable telomerase activity. EMBO J. 14, 4240±4248.
ribosome entry site. After 48 hr, the virus was collected, and retrovi-
Chadeneau, C., Siegel, P., Harley, C.B., Muller, W., and Bacchetti, S.ral infections of the target fibroblasts were carried out as described
(1995). Telomerase activity in normal and malignant murine tissues.(Serrano et al., 1997). Sixteen hours after the infection, cells were
Oncogene 11, 893±898.selected in 2 mg/ml puromycin for 2 days and collected for transfor-
Conzen, S.D., and Cole, C.N. (1995). The three transforming regionsmation assays and tumor formation studies in nude mice.
of SV40 T antigen are required for immortalization of primary mouse
embryo fibroblasts. Oncogene 11, 2295±2302.Nude Mouse Tumor Assays
BALB/c nude mice (Taconic Farms) were injected at each of the Cooke, H.J., and Smith, B.A. (1986). Variability at the telomeres of
two sites with 0.5 3 106 cells transformed with TAg and rasv12. For human X/Y pseudoautosomal region. Cold Spring Harbor Symp.
the E1A and rasv12 transduced foci, 1.5 3 106 cells were injected Quant. Biol. LI, 213±219.
to each site. Mice were monitored daily, and tumor growth was Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider,
measured by caliper every 3 days. Tumors were removed from all C.W., Harley, C.B., and Bacchetti, S. (1992). Telomere shortening
of the animals in a given experiment when some animals had sub- associated with chromosome instability is arrested in immortal cells
stantially large tumors. which express telomerase activity. EMBO J. 11, 1921±1929.
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